These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 9673796

  • 1. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM, Traynor JR.
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [Abstract] [Full Text] [Related]

  • 2. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 5. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML, Mendelsohn LG, Mitch CH, Zimmerman DM.
    Receptor; 1994 Sep 12; 4(1):43-53. PubMed ID: 8038706
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR, Guo L, Coop A, Lewis JW, Woods JH.
    J Pharmacol Exp Ther; 1999 Dec 12; 291(3):1093-9. PubMed ID: 10565829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD, Collins N, Stropova D, Davis P, Yamamura HI, Porreca F, Hruby VJ.
    J Med Chem; 1996 Mar 01; 39(5):1136-41. PubMed ID: 8676350
    [Abstract] [Full Text] [Related]

  • 11. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH, Davis P, Hruby VJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 01; 266(2):577-84. PubMed ID: 8394911
    [Abstract] [Full Text] [Related]

  • 12. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R, Niizawa S, Koike K, Sagara T, Kanematsu K, Takayanagi I.
    Arch Int Pharmacodyn Ther; 1996 Aug 01; 331(2):136-52. PubMed ID: 8937625
    [Abstract] [Full Text] [Related]

  • 13. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K, Takayanagi I, Hirakura Y, Matsueda R.
    Arch Int Pharmacodyn Ther; 1991 Aug 01; 313():33-46. PubMed ID: 1687773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.
    Dixon DM, Traynor JR.
    Br J Pharmacol; 1990 Nov 01; 101(3):674-8. PubMed ID: 1981690
    [Abstract] [Full Text] [Related]

  • 16. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y, Simon EJ.
    J Pharmacol Exp Ther; 1984 Aug 01; 230(2):383-6. PubMed ID: 6086884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S, Ishmael JE, Murray TF, Grandy DK, DeLander GE, Kieffer BL, Aldrich JV.
    J Med Chem; 1997 Apr 11; 40(8):1211-8. PubMed ID: 9111295
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H, Murray TF, DeLander GE, Schmidt WK, Aldrich JV.
    J Med Chem; 1997 Aug 15; 40(17):2733-9. PubMed ID: 9276018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.